The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mono Hepatitis B Vaccine Market Research Report 2025
Synopsis
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
The global Mono Hepatitis B Vaccine market was valued at US$ 1063 million in 2023 and is anticipated to reach US$ 1179.8 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Mono Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mono Hepatitis B Vaccine.
Report Scope
The Mono Hepatitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mono Hepatitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mono Hepatitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mono Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mono Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
The global Mono Hepatitis B Vaccine market was valued at US$ 1063 million in 2023 and is anticipated to reach US$ 1179.8 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Mono Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mono Hepatitis B Vaccine.
Report Scope
The Mono Hepatitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mono Hepatitis B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mono Hepatitis B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mono Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mono Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mono Hepatitis B Vaccine Market Overview
1.1 Product Overview and Scope of Mono Hepatitis B Vaccine
1.2 Mono Hepatitis B Vaccine Segment by Type
1.2.1 Global Mono Hepatitis B Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Mono Hepatitis B Vaccine Segment by Application
1.3.1 Global Mono Hepatitis B Vaccine Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Mono Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Mono Hepatitis B Vaccine Revenue 2019-2030
1.4.2 Global Mono Hepatitis B Vaccine Sales 2019-2030
1.4.3 Global Mono Hepatitis B Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mono Hepatitis B Vaccine Market Competition by Manufacturers
2.1 Global Mono Hepatitis B Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mono Hepatitis B Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mono Hepatitis B Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Mono Hepatitis B Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mono Hepatitis B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mono Hepatitis B Vaccine, Product Type & Application
2.7 Mono Hepatitis B Vaccine Market Competitive Situation and Trends
2.7.1 Mono Hepatitis B Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mono Hepatitis B Vaccine Players Market Share by Revenue
2.7.3 Global Mono Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mono Hepatitis B Vaccine Retrospective Market Scenario by Region
3.1 Global Mono Hepatitis B Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mono Hepatitis B Vaccine Global Mono Hepatitis B Vaccine Sales by Region: 2019-2030
3.2.1 Global Mono Hepatitis B Vaccine Sales by Region: 2019-2024
3.2.2 Global Mono Hepatitis B Vaccine Sales by Region: 2025-2030
3.3 Global Mono Hepatitis B Vaccine Global Mono Hepatitis B Vaccine Revenue by Region: 2019-2030
3.3.1 Global Mono Hepatitis B Vaccine Revenue by Region: 2019-2024
3.3.2 Global Mono Hepatitis B Vaccine Revenue by Region: 2025-2030
3.4 North America Mono Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 North America Mono Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mono Hepatitis B Vaccine Sales by Country (2019-2030)
3.4.3 North America Mono Hepatitis B Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mono Hepatitis B Vaccine Market Facts & Figures by Country
3.5.1 Europe Mono Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mono Hepatitis B Vaccine Sales by Country (2019-2030)
3.5.3 Europe Mono Hepatitis B Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mono Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Mono Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mono Hepatitis B Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Mono Hepatitis B Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mono Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Mono Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mono Hepatitis B Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Mono Hepatitis B Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mono Hepatitis B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Mono Hepatitis B Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mono Hepatitis B Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mono Hepatitis B Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mono Hepatitis B Vaccine Sales by Type (2019-2030)
4.1.1 Global Mono Hepatitis B Vaccine Sales by Type (2019-2024)
4.1.2 Global Mono Hepatitis B Vaccine Sales by Type (2025-2030)
4.1.3 Global Mono Hepatitis B Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Mono Hepatitis B Vaccine Revenue by Type (2019-2030)
4.2.1 Global Mono Hepatitis B Vaccine Revenue by Type (2019-2024)
4.2.2 Global Mono Hepatitis B Vaccine Revenue by Type (2025-2030)
4.2.3 Global Mono Hepatitis B Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Mono Hepatitis B Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mono Hepatitis B Vaccine Sales by Application (2019-2030)
5.1.1 Global Mono Hepatitis B Vaccine Sales by Application (2019-2024)
5.1.2 Global Mono Hepatitis B Vaccine Sales by Application (2025-2030)
5.1.3 Global Mono Hepatitis B Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Mono Hepatitis B Vaccine Revenue by Application (2019-2030)
5.2.1 Global Mono Hepatitis B Vaccine Revenue by Application (2019-2024)
5.2.2 Global Mono Hepatitis B Vaccine Revenue by Application (2025-2030)
5.2.3 Global Mono Hepatitis B Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Mono Hepatitis B Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Mono Hepatitis B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NCPC Mono Hepatitis B Vaccine Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Mono Hepatitis B Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Kangtai Mono Hepatitis B Vaccine Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dynavax Mono Hepatitis B Vaccine Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hissen Mono Hepatitis B Vaccine Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Mono Hepatitis B Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LG Life Sciences Mono Hepatitis B Vaccine Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Mono Hepatitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Serum Institute Mono Hepatitis B Vaccine Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mono Hepatitis B Vaccine Industry Chain Analysis
7.2 Mono Hepatitis B Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mono Hepatitis B Vaccine Production Mode & Process
7.4 Mono Hepatitis B Vaccine Sales and Marketing
7.4.1 Mono Hepatitis B Vaccine Sales Channels
7.4.2 Mono Hepatitis B Vaccine Distributors
7.5 Mono Hepatitis B Vaccine Customers
8 Mono Hepatitis B Vaccine Market Dynamics
8.1 Mono Hepatitis B Vaccine Industry Trends
8.2 Mono Hepatitis B Vaccine Market Drivers
8.3 Mono Hepatitis B Vaccine Market Challenges
8.4 Mono Hepatitis B Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mono Hepatitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mono Hepatitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mono Hepatitis B Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mono Hepatitis B Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Mono Hepatitis B Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mono Hepatitis B Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mono Hepatitis B Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mono Hepatitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mono Hepatitis B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mono Hepatitis B Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mono Hepatitis B Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Mono Hepatitis B Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mono Hepatitis B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mono Hepatitis B Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mono Hepatitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mono Hepatitis B Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Mono Hepatitis B Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Mono Hepatitis B Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Mono Hepatitis B Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Mono Hepatitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mono Hepatitis B Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Mono Hepatitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mono Hepatitis B Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Mono Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mono Hepatitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Mono Hepatitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Mono Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mono Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mono Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mono Hepatitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Mono Hepatitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Mono Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mono Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mono Hepatitis B Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mono Hepatitis B Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Mono Hepatitis B Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Mono Hepatitis B Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mono Hepatitis B Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mono Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mono Hepatitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Mono Hepatitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Mono Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mono Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mono Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mono Hepatitis B Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Mono Hepatitis B Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Mono Hepatitis B Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mono Hepatitis B Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mono Hepatitis B Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Mono Hepatitis B Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Mono Hepatitis B Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Mono Hepatitis B Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Mono Hepatitis B Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mono Hepatitis B Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mono Hepatitis B Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Mono Hepatitis B Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Mono Hepatitis B Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Mono Hepatitis B Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Mono Hepatitis B Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Mono Hepatitis B Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Mono Hepatitis B Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mono Hepatitis B Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mono Hepatitis B Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Mono Hepatitis B Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Mono Hepatitis B Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. NCPC Corporation Information
Table 76. NCPC Description and Business Overview
Table 77. NCPC Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. NCPC Mono Hepatitis B Vaccine Product
Table 79. NCPC Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Mono Hepatitis B Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Bio Kangtai Corporation Information
Table 86. Bio Kangtai Description and Business Overview
Table 87. Bio Kangtai Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bio Kangtai Mono Hepatitis B Vaccine Product
Table 89. Bio Kangtai Recent Developments/Updates
Table 90. Dynavax Corporation Information
Table 91. Dynavax Description and Business Overview
Table 92. Dynavax Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dynavax Mono Hepatitis B Vaccine Product
Table 94. Dynavax Recent Developments/Updates
Table 95. Hissen Corporation Information
Table 96. Hissen Description and Business Overview
Table 97. Hissen Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hissen Mono Hepatitis B Vaccine Product
Table 99. Hissen Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. KM Biologics Mono Hepatitis B Vaccine Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LG Life Sciences Mono Hepatitis B Vaccine Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Mono Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Serum Institute Mono Hepatitis B Vaccine Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Mono Hepatitis B Vaccine Distributors List
Table 118. Mono Hepatitis B Vaccine Customers List
Table 119. Mono Hepatitis B Vaccine Market Trends
Table 120. Mono Hepatitis B Vaccine Market Drivers
Table 121. Mono Hepatitis B Vaccine Market Challenges
Table 122. Mono Hepatitis B Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mono Hepatitis B Vaccine
Figure 2. Global Mono Hepatitis B Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mono Hepatitis B Vaccine Market Share by Type in 2023 & 2030
Figure 4. Yeast Derived Product Picture
Figure 5. CHO Derived Product Picture
Figure 6. Global Mono Hepatitis B Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Mono Hepatitis B Vaccine Market Share by Application in 2023 & 2030
Figure 8. Children
Figure 9. Adult
Figure 10. Global Mono Hepatitis B Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Mono Hepatitis B Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Mono Hepatitis B Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Mono Hepatitis B Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Mono Hepatitis B Vaccine Report Years Considered
Figure 15. Mono Hepatitis B Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Mono Hepatitis B Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Mono Hepatitis B Vaccine Players: Market Share by Revenue in 2023
Figure 18. Mono Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Mono Hepatitis B Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Mono Hepatitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Mono Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Mono Hepatitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Mono Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Mono Hepatitis B Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Mono Hepatitis B Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Mono Hepatitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Mono Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Mono Hepatitis B Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Mono Hepatitis B Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Mono Hepatitis B Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Mono Hepatitis B Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Mono Hepatitis B Vaccine by Type (2019-2030)
Figure 54. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Mono Hepatitis B Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Mono Hepatitis B Vaccine by Application (2019-2030)
Figure 57. Global Mono Hepatitis B Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 58. Mono Hepatitis B Vaccine Value Chain
Figure 59. Mono Hepatitis B Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
